@misc{indiciaeb9a9456618c4,
  title = {FXR inhibition reduces ACE2 expression, SARS-CoV-2 infection and may improve COVID-19 outcome},
  author = {Brevini, T. and Maes, M. and Webb, G. J. and Gelson, W. T. H. and Forrest, S. and Mlcochova, P. and Dillon, S. and Varankar, S. and Darvish-Damavandi, M. and Mulcahy, V. L. and Kuc, R. E. and Williams, T. L. and Galanakis, V. and Vila-Gonzalez, M. and Tysoe, O. C. and Muraro, D. and Crozier, T. W. M. and Bargehr, J. and Sinha, S. and Upponi, S. S. and Swift, L. and Saeb-Parsy, K. and Davies, S. E. and Marjot, T. and Barnes, E. and Lohse, A. W. and Moon, A. M. and Barritt, S. A. and Gupta, R. K. and Baker, S. and Davenport, A. P. and Corbett, G. and Buczacki, S. J. A. and Lee, J.-H. and Gibbs, P. and Butler, A. J. and Watson, C. J. E. and Mells, G. F. and Dougan, G. and vallier, L. and Sampaziotis, F.},
  year = {2021},
  doi = {10.1101/2021.06.06.446781},
  url = {https://www.biorxiv.org/content/10.1101/2021.06.06.446781v1},
  note = {Source identifier: 10.1101/2021.06.06.446781}
}